HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial.

AbstractAIM:
To assess the efficacy of cisapride in reducing ileus persisting to the tenth postoperative day after neonatal abdominal surgery.
METHODS:
A prospective, randomised, double blind trial comparing rectal cisapride (1.4-2.3 mg/kg/day) with placebo over seven days was undertaken in 33 neonates.
RESULTS:
Seven of 12 (58%) patients receiving placebo and eight of 11 (73%) receiving cisapride achieved a first sustained feed during treatment. Of those receiving cisapride, the first sustained feed occurred at 2.3 days (SEM 0.6) compared with 4.7 days (SEM 0.8) with placebo. By the seventh day the mean daily net enteral balance was 69 (SEM 18) ml/kg in the cisapride subgroup and 17 (SEM 8) ml/kg for those receiving placebo. Stool was passed on 6.3 (SEM 0.4) treatment days in the cisapride subgroup compared with 4.1 (SEM 1.0) treatment days in the placebo subgroup.
CONCLUSION:
Cisapride is effective in neonates with a prolonged ileus after abdominal surgery.
AuthorsA Lander, R Redkar, G Nicholls, A Lawson, S R Choudhury, J J Corkery, P Gornall, R G Buick, I W Booth
JournalArchives of disease in childhood. Fetal and neonatal edition (Arch Dis Child Fetal Neonatal Ed) Vol. 77 Issue 2 Pg. F119-22 (Sep 1997) ISSN: 1359-2998 [Print] England
PMID9377133 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gastrointestinal Agents
  • Piperidines
  • Cisapride
Topics
  • Administration, Rectal
  • Cisapride
  • Double-Blind Method
  • Gastrointestinal Agents (therapeutic use)
  • Gastrointestinal Motility (drug effects)
  • Humans
  • Infant, Newborn
  • Intestinal Obstruction (drug therapy)
  • Piperidines (therapeutic use)
  • Postoperative Complications (drug therapy)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: